Similar Articles
271 Exploring predictive markers for liver failure post-hepatectomy in hepatocellular carcinoma patients
272 Hepatocellular carcinoma-the role of the underlying liver disease in clinical practice
273 Present and future of new systemic therapies for early and intermediate stages of hepatocellular carcinoma
274 Cell division cyclin 25C knockdown inhibits hepatocellular carcinoma development by inducing endoplasmic reticulum stress
275 Coexistence of liver abscess, hepatic cystic echinococcosis and hepatocellular carcinoma: A case report
276 Albumin–bilirubin grade as a predictor of survival in hepatocellular carcinoma patients with thrombocytopenia
277 Perioperative remedial antiviral therapy in hepatitis B virus-related hepatocellular carcinoma resection: How to achieve a better outcome
278 Plexin domain-containing 1 may be a biomarker of poor prognosis in hepatocellular carcinoma patients, may mediate immune evasion
279 Multidisciplinary comprehensive treatment of massive hepatocellular carcinoma with hemorrhage: A case report and review of literature
280 Diagnostic and prognostic performances of GALAD score in staging and 1-year mortality of hepatocellular carcinoma: A prospective study
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA